Joint research aims to find microbiome-based drugs that will enhance patient response and reduce adverse effects of immunotherapies in melanoma patients

Unit of Swiss multinational firm strikes multiyear strategic collaboration with Israeli life-sciences firm that cultures, ferments and delivers bacterial communities for healthcare